Allison Tyler

Phase 1 dose‐escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma

Brian I. Rini, Mark N. Stein, P. Shannon et al. · Cancer · 2010 · 153 citations

A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid Tumors

Brian I. Rini, Jorge A. García, Matthew M. Cooney et al. · Clinical Cancer Research · 2009 · 85 citations · Full text

HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer

Mohammad Alyamani, Hamid Emamekhoo, Sunho Park et al. · Journal of Clinical Investigation · 2018 · 52 citations · Full text

The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma

Pedro C. Barata, Alfonso Gómez de Liaño, Prateek Mendiratta et al. · British Journal of Cancer · 2018 · 47 citations · Full text

Clinical Immunology, Immunodeficiencies, Immunology +24

A phase 2 study of OSI-906 (linsitinib, an insulin-like growth factor receptor-1 inhibitor) in patients with asymptomatic or mildly symptomatic (non-opioid requiring) metastatic castrate resistant prostate cancer (CRPC)

Pedro C. Barata, Matthew M. Cooney, Allison Tyler et al. · Investigational New Drugs · 2018 · 41 citations

Urology, Non-opioid Requiring, Medicine +6